This technology is an attention-based deep learning for cardiac right ventricular volume quantification using 2D echocardiography.

This technology is a set of small molecule agonists of the Sigma non-opioid receptor for the treatment of Timothy Syndrome.

This technology is a pluripotent stem cell derived cardiomyocyte model of early-onset restrictive cardiomyopathy (RCM) based on a mutation in Filamin C (FLNC) which can be harnessed to recapitulate RCM phenotypes and to screen and identify therapeutic compounds for RCM.

This technology is a small molecule protein therapeutic for systolic heart failure, which improves contractility without an unwanted rise in a patient’s heart rate.

This technology is a new composition using ubiquinone as an anesthetic and sedative for clinical use.

This technology consists of a wearable wrist device that provides continuous blood pressure monitoring that is self-calibrating and utilizes a combination of positional sensors and machine-learning algorithms to adjust for changes in hydrostatic pressure due to arm movement.

This technology, BeatProfiler, is a desktop graphical-user-interface (GUI) that leverages deep learning for high-throughput, streamlined analysis of in vitro human cardiac cells and engineered tissues, primarily aimed at accelerating drug development and disease phenotyping in cardiovascular research.

This technology is a protein for the treatment of cardiac and coronary artery inflammation that can be used as a potential therapeutic approach for vascular conditions like Kawasaki disease (KD) and immune mediated myocarditis.

This technology describes an inducible mouse line for the expression of unstable TRIP8b protein to study ion channel localization and function.

This technology is a digital health model to improve access and adherence to cardiac rehabilitation by moving clinic-based treatment to the home.

This technology is a method of monitoring catheter ablation of faulty electrical pathways in the myocardial tissue of the heart using ultrasound catheter-guided intracardiac echocardiography.

This technology is an in vitro human cardiac muscle tissue platform that can be used to diagnose myocarditis.

This technology describes an inducible mouse line for the inhibition of cardiac-specific reactive oxygen species production.

This technology, FixR, is a modified peptide and delivery system aimed at reducing pathogenic late sodium currents, which are implicated in cardiac and neurological diseases, including cardiac arrhythmia.

This technology is a diagnostic tool combining electrocardiography with the power of deep learning algorithms to detect moderate to severe aortic stenosis, aortic regurgitation, and mitral regurgitation.